Skip to content

Company profile · 3 min read

83 Sciences: materials discovery from unpublished experimental data

AI-native materials-discovery partner for industrial R&D teams and academic labs with valuable unstructured experiments.

83 Sciences uses AI to turn unpublished experimental data into materials-discovery work for industrial R&D and academic labs. The decision is whether a team wants a partner that can structure its discarded experiments and move toward a material, paper, patent, or scale-up question—not just another model trained on published literature.

What it does

83 Sciences says it captures and structures data from voice notes through instrument output, builds a queryable record of experiments, and uses agents to propose materials and process conditions. Its public priority areas include critical minerals, energy storage, catalysis and chemicals, life-science solid forms, and semiconductors (83 Sciences homepage; 83 Sciences team).

FactWhat the public sources say
BuyerIndustrial R&D teams and academic labs
InputUnpublished experimental data, from lab notes to instrument output
OutputDiscovery candidates, process conditions, papers, patents, and commercialization paths
Public timing claimThe homepage says it can reach a first new material from partner data in under six weeks
FoundersIan Naccarella, Eric Riesel, and Yankang Yang

Why it fits

The wedge is the data most frontier models do not see: failed experiments, tacit lab context, and process details that never became a paper. An industrial team can care less about a benchmark score than whether the system learns its actual materials history and produces a candidate that survives a real experiment. The academic path adds a different buyer job: turn years of unstructured work into papers, citations, and commercialization opportunities.

The public results are company claims. The YC launch says the team has discovered a novel material and drafted a manuscript; the homepage says more than 85% of experimental data is discarded, cites $100B+ in lost R&D value, and advertises the under-six-week path (83 Sciences YC launch; 83 Sciences homepage). A buyer should resolve data ownership, reproducibility, lab validation, IP terms, scale-up support, and how negative results are preserved rather than silently filtered.

The founder mix matches the commercial-science problem. YC describes Naccarella as having worked on battery materials at Sila, Riesel as an MIT inorganic-chemistry PhD and ML researcher, and Yang as a former BCG principal who led an AI program (YC company profile). Pricing was not published; the site directs industry teams to scope a discovery contract.

Short version: 83 Sciences is a strong fit when valuable experiments are trapped in lab files and the buyer can fund real validation. It is not a shortcut around chemistry, ownership, or manufacturing constraints.

Sources checked — 2026-09-19

Cohort context

83 Sciences is listed in Summer 2026. In our 2026-09-18 directory snapshot, 56 of 232 listed companies in that cohort have YC’s primary industry label Industrials (24.1%). This is a current-directory comparison, not an original intake count or a performance ranking. Nine-cohort dataset.

Public website snapshot

Observed 2026-09-19 16:18 UTC in raw homepage HTML. This records visible metadata and advertised links, not agent execution or product quality.

SignalHomepage observation
Product description metadataObserved
Canonical linkNot observed in this response
H1 or H2 headingObserved
Typed structured dataNot observed in this response
Docs/developer linkNot observed in this response
Pricing linkNot observed in this response
llms.txt linkNot observed in this response
Markdown alternateNot observed in this response

Public observations · Collection method. Missing links here do not establish that a capability or file is absent elsewhere.

Ali Abouelatta

About the author

Cofounder of Lazyweb (a16z Speedrun). Previously grew subscriptions and built native ads at Duolingo. Writes First1000 (90,000+ subscribers).

I cofound Lazyweb, which publishes this site. This is an owner-written publication, not an independent testing organization. Research notes distinguish observations, sourced reporting and editorial judgment.

First1000X